STOCK TITAN

NU SKIN (NUS) CEO Ryan Napierski receives 282,353-share equity grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

NU SKIN ENTERPRISES, INC. President and CEO Ryan S. Napierski reported receiving an equity grant of 282,353 shares of Class A Common Stock on March 6, 2026. The shares were acquired as a grant or award at a reported price of $0.00 per share. Following this award, his directly held stake increased to 1,001,905 Class A shares.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
NAPIERSKI RYAN S

(Last) (First) (Middle)
C/O NU SKIN ENTERPRISES, INC.
75 W CENTER STREET

(Street)
PROVO UT 84601

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NU SKIN ENTERPRISES, INC. [ NUS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President and CEO
3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 03/06/2026 A 282,353 A $0.00 1,001,905 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/s/ Gregory Belliston as Attorney-in-Fact for Ryan S. Napierski 03/09/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did NU SKIN (NUS) CEO Ryan Napierski report on this Form 4?

He reported an equity grant of 282,353 Class A Common Stock shares. The transaction code "A" shows it was a grant or award, not an open-market purchase, and it increased his directly held stake to 1,001,905 shares.

Was the NU SKIN (NUS) CEO’s 282,353-share transaction a purchase or a grant?

It was a grant or award, not a cash purchase. The filing uses transaction code "A" and describes the action as a grant or award acquisition, with a reported price of $0.00 per share for the 282,353 shares.

How many NU SKIN (NUS) shares does the CEO own after this reported grant?

After the reported grant, Ryan S. Napierski directly holds 1,001,905 Class A Common Stock shares. This total includes the 282,353 shares received in the March 6, 2026 grant or award transaction disclosed in the Form 4.

What is the significance of transaction code "A" in this NU SKIN (NUS) Form 4?

Transaction code "A" indicates a grant, award, or other acquisition of securities. In this case, it reflects an equity award of 282,353 Class A Common Stock shares to the CEO, rather than an open-market buy or sell transaction.

Did NU SKIN (NUS) CEO’s Form 4 show any share sales or disposals?

No sales or disposals were reported in this Form 4 excerpt. The only listed transaction is a grant or award acquisition of 282,353 Class A Common Stock shares, increasing the CEO’s directly owned holdings to 1,001,905 shares.
Nu Skin Enter

NYSE:NUS

View NUS Stock Overview

NUS Rankings

NUS Latest News

NUS Latest SEC Filings

NUS Stock Data

367.21M
45.82M
Household & Personal Products
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
PROVO